7 results
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
Polyangiitis (MPA ... Management Algorithm ... RTX, GC+CYC, GC+AZA ... #Management #Treatment ... #ACR2021 #Guidelines
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary
 • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
(SLE) - Diagnosis ... Workup: - ANA ... anti-MPO - Negative ... life-threatening • Treatment ... #Management #Summary
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
Workup: - ANA ... Workup: - ANA ... Usual therapeutic management ... #rheumatology #diagnosis ... #management
Systemic Lupus Erythematosus - Summary
Antinuclear (ANA) - 95% - Initial screening test
Anti-dsDNA - 50%
 • Associated
- Summary Antinuclear ... (ANA) - 95% - Initial ... severe disease Treatment ... #diagnosis #rheumatology ... #management
Pulmonary Renal Syndromes - OnePager Summary
Autoimmune ANCA vasculitis (AAV): GPA (granulomatous with polyangiitis), EGPA (eosinophilic granulomatosis
Syndromes - OnePager Summary ... Autoimmune ANCA ... polyangiitis), MPA ... Auto-antibodies: ANCA ... #management #treatment
Drug Induced Lupus (DIL)
 • Epidemiology: -10% of all lupus cases, drug-dependent, 4:1 to 1:1 F:M
Workup: - ANA ... anti-MPO - Seen ... constitutional symptoms • Treatment ... #rheumatology #diagnosis ... #treatment #management
Relapsing Polychondritis

What is it?
Recurrent inflammation of the cartilage in the body (Autoimmune disorder)

Who?
• Most frequently: 40
Large vessels (aorta ... • Lymphoma • GPA ... Nonspecific ↑ ESR, CRP, ANA ... affected tissue Treatment ... #management